Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir

被引:75
作者
Cutrell, AG [1 ]
Hernandez, JE
Fleming, JW
Edwards, MT
Moore, MA
Brothers, CH
Scott, TR
机构
[1] GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC 27709 USA
[3] Tomorrow Associates Inc, Cary, NC USA
[4] GlaxoSmithKline, Regulatory Affairs, Res Triangle Pk, NC USA
关键词
D O I
10.1345/aph.1E202
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:2171 / 2172
页数:2
相关论文
共 4 条
  • [1] HERNANDEZ J, 2003, 5 INT WORKSH ADV DRU
  • [2] Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
    Hetherington, S
    Hughes, AR
    Mosteller, M
    Shortino, D
    Baker, KL
    Spreen, W
    Lai, E
    Davies, K
    Handley, A
    Dow, DJ
    Fling, ME
    Stocum, M
    Bowman, C
    Thurmond, LM
    Roses, AD
    [J]. LANCET, 2002, 359 (9312) : 1121 - 1122
  • [3] Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
    Hetherington, S
    McGuirk, S
    Powell, G
    Cutrell, A
    Naderer, O
    Spreen, B
    Lafon, S
    Pearce, G
    Steel, H
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (10) : 1603 - 1614
  • [4] Risk factor analysis of hypersensitivity reactions to abacavir
    Symonds, W
    Cutrell, A
    Edwards, M
    Steel, H
    Spreen, B
    Powell, G
    McGuirk, S
    Hetherington, S
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (04) : 565 - 573